In This Section


NAMI Presses CMS to Ensure that Atypical Antipsychotics are Included in the Upcoming Medicare Part B Competitive Acquisition Program (CAP)

August 4, 2005

Earlier this year, NAMI pushed the Centers for Medicare and Medicaid Services (CMS) to include atypical antipsychotic medications in the Part B CAP program covering non-self-injectible medications administered in physician offices and clinics.  In July, CMS issued rules clarifying that antipsychotic medications will be included in the program.  NAMI's letter to CMS is posted below.


Related Files

Letter to CMS Regarding Medicare (PDF File)
Back to top